Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-12-18FDA Approved: REVATIO — Supplemental Application (PFIZER LABORATORIES DIV PFIZER INC)
FDA approved a supplemental application for REVATIO (sildenafil citrate) submitted by Pfizer Laboratories Division Pfizer Inc.
-
FDA approval · 2007-11-29FDA Approved: LETAIRIS — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for LETAIRIS (ambrisentan) submitted by Gilead Sciences, Inc. The action pertains to changes in …
-
FDA approval · 2007-10-18FDA Approved: SILDENAFIL CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for sildenafil citrate from Mylan Pharmaceuticals Inc.
-
FDA approval · 2007-06-15FDA Approved: LETAIRIS — Original Application (Gilead Sciences, Inc.)
The FDA approves LETAIRIS (ambrisentan) in an original application from Gilead Sciences for the treatment of pulmonary arterial hypertension…
-
FDA approval · 2007-06-01FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
FDA approved a supplemental application for TRACLEER (bosentan) filed by Actelion Pharmaceuticals US, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-02-15FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)
FDA approved a supplemental application for TRACLEER (bosentan) from Actelion Pharmaceuticals US, Inc., updating the product's labeling as p…
-
FDA approval · 2006-07-27FDA Approved: REVATIO — Supplemental Application (PFIZER LABORATORIES DIV PFIZER INC)
The FDA approved a supplemental application for REVATIO (sildenafil citrate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2006-07-19FDA Approved: REVATIO — Supplemental Application (PFIZER LABORATORIES DIV PFIZER INC)
The FDA approved a supplemental application for REVATIO (sildenafil citrate) from Pfizer Laboratories, resulting in changes to the product l…